APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genomics Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Genomics Products Market Outlook and Growth Opportunities 2026

8 January 2026215 pages

Choose your research edition.

Industry ResearchGenomics Products Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Genomics Products Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Genomics Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genomics Products Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Genomics Products Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Genomics Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Genomics Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genomics Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genomics Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Genomics Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Genomics Products market include Zymo Research, Active Motif, Thermo Fisher Scientific, Cayman Chemical, Diagenode, Abcam, New England Biolabs, Merck & Co. and Qiagen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Genomics Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genomics Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genomics Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Genomics Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Genomics Products Segment by Company

Zymo Research

Active Motif

Thermo Fisher Scientific

Cayman Chemical

Diagenode

Abcam

New England Biolabs

Merck & Co.

Qiagen

Bio-Rad

Illumina

Agilent

Perkinelmer

Epizyme Inc.

CellCentric Ltd.

ValiRx plc

EpiGentek

Syndax Pharmaceuticals

Spectrum Pharmaceuticals

Promega

Novartis

Genomics Products Segment by Type

Reagents and Consumables

Bioinformatics and Software

Instruments and Systems

Others

Genomics Products Segment by Application

Pharmaceutical & Biotechnological

Companies Academic & Research Institutes Contract

Research Organizations

Others

Genomics Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Genomics Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Genomics Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Genomics Products significant trends, drivers, influence factors in global and regions.

6. To analyze Genomics Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genomics Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genomics Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genomics Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Genomics Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genomics Products industry.

Chapter 3: Detailed analysis of Genomics Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Genomics Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Genomics Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Genomics Products Industry Trends Table 2. Genomics Products Industry Drivers Table 3. Genomics Products Industry Opportunities and Challenges Table 4. Genomics Products Industry Restraints Table 5. Global Genomics Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Genomics Products Revenue Share by Company (2021-2026) Table 7. Global Genomics Products Sales Volume by Company (k units) & (2021-2026) Table 8. Global Genomics Products Sales Volume Share by Company (2021-2026) Table 9. Global Genomics Products Average Price (USD/unit) of Company (2021-2026) Table 10. Global Genomics Products Company Ranking, (2024-2026) & (USD Million) Table 11. Global Genomics Products Key Company Manufacturing Base & Headquarters Table 12. Global Genomics Products Company, Product Type & Application Table 13. Global Genomics Products Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Genomics Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Reagents and Consumables Table 18. Significant Companies of Bioinformatics and Software Table 19. Significant Companies of Instruments and Systems Table 20. Significant Companies of Others Table 21. Global Genomics Products Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Genomics Products Sales Volume by Type (2021-2026) & (k units) Table 23. Global Genomics Products Sales Volume by Type (2027-2032) & (k units) Table 24. Global Genomics Products Sales Volume Share by Type (2021-2026) Table 25. Global Genomics Products Sales Volume Share by Type (2027-2032) Table 26. Global Genomics Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Genomics Products Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Genomics Products Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Genomics Products Sales Value Share by Type (2021-2026) Table 30. Global Genomics Products Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pharmaceutical & Biotechnological Table 32. Significant Companies of Companies Academic & Research Institutes Contract Table 33. Significant Companies of Research Organizations Table 34. Significant Companies of Others Table 35. Global Genomics Products Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Genomics Products Sales Volume by Application (2021-2026) & (k units) Table 37. Global Genomics Products Sales Volume by Application (2027-2032) & (k units) Table 38. Global Genomics Products Sales Volume Share by Application (2021-2026) Table 39. Global Genomics Products Sales Volume Share by Application (2027-2032) Table 40. Global Genomics Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Genomics Products Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Genomics Products Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Genomics Products Sales Value Share by Application (2021-2026) Table 44. Global Genomics Products Sales Value Share by Application (2027-2032) Table 45. Global Genomics Products Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Genomics Products Sales by Region (2021-2026) & (k units) Table 47. Global Genomics Products Sales Market Share by Region (2021-2026) Table 48. Global Genomics Products Sales by Region (2027-2032) & (k units) Table 49. Global Genomics Products Sales Market Share by Region (2027-2032) Table 50. Global Genomics Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Genomics Products Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Genomics Products Sales Value Share by Region (2021-2026) Table 53. Global Genomics Products Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Genomics Products Sales Value Share by Region (2027-2032) Table 55. Global Genomics Products Market Average Price (USD/unit) by Region (2021-2026) Table 56. Global Genomics Products Market Average Price (USD/unit) by Region (2027-2032) Table 57. Global Genomics Products Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Genomics Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Genomics Products Sales by Country (2021-2026) & (k units) Table 60. Global Genomics Products Sales Market Share by Country (2021-2026) Table 61. Global Genomics Products Sales by Country (2027-2032) & (k units) Table 62. Global Genomics Products Sales Market Share by Country (2027-2032) Table 63. Global Genomics Products Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Genomics Products Sales Value Market Share by Country (2021-2026) Table 65. Global Genomics Products Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Genomics Products Sales Value Market Share by Country (2027-2032) Table 67. Zymo Research Company Information Table 68. Zymo Research Business Overview Table 69. Zymo Research Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Zymo Research Genomics Products Product Portfolio Table 71. Zymo Research Recent Development Table 72. Active Motif Company Information Table 73. Active Motif Business Overview Table 74. Active Motif Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Active Motif Genomics Products Product Portfolio Table 76. Active Motif Recent Development Table 77. Thermo Fisher Scientific Company Information Table 78. Thermo Fisher Scientific Business Overview Table 79. Thermo Fisher Scientific Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Thermo Fisher Scientific Genomics Products Product Portfolio Table 81. Thermo Fisher Scientific Recent Development Table 82. Cayman Chemical Company Information Table 83. Cayman Chemical Business Overview Table 84. Cayman Chemical Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Cayman Chemical Genomics Products Product Portfolio Table 86. Cayman Chemical Recent Development Table 87. Diagenode Company Information Table 88. Diagenode Business Overview Table 89. Diagenode Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Diagenode Genomics Products Product Portfolio Table 91. Diagenode Recent Development Table 92. Abcam Company Information Table 93. Abcam Business Overview Table 94. Abcam Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Abcam Genomics Products Product Portfolio Table 96. Abcam Recent Development Table 97. New England Biolabs Company Information Table 98. New England Biolabs Business Overview Table 99. New England Biolabs Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. New England Biolabs Genomics Products Product Portfolio Table 101. New England Biolabs Recent Development Table 102. Merck & Co. Company Information Table 103. Merck & Co. Business Overview Table 104. Merck & Co. Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Merck & Co. Genomics Products Product Portfolio Table 106. Merck & Co. Recent Development Table 107. Qiagen Company Information Table 108. Qiagen Business Overview Table 109. Qiagen Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Qiagen Genomics Products Product Portfolio Table 111. Qiagen Recent Development Table 112. Bio-Rad Company Information Table 113. Bio-Rad Business Overview Table 114. Bio-Rad Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Bio-Rad Genomics Products Product Portfolio Table 116. Bio-Rad Recent Development Table 117. Illumina Company Information Table 118. Illumina Business Overview Table 119. Illumina Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Illumina Genomics Products Product Portfolio Table 121. Illumina Recent Development Table 122. Agilent Company Information Table 123. Agilent Business Overview Table 124. Agilent Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Agilent Genomics Products Product Portfolio Table 126. Agilent Recent Development Table 127. Perkinelmer Company Information Table 128. Perkinelmer Business Overview Table 129. Perkinelmer Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Perkinelmer Genomics Products Product Portfolio Table 131. Perkinelmer Recent Development Table 132. Epizyme Inc. Company Information Table 133. Epizyme Inc. Business Overview Table 134. Epizyme Inc. Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Epizyme Inc. Genomics Products Product Portfolio Table 136. Epizyme Inc. Recent Development Table 137. CellCentric Ltd. Company Information Table 138. CellCentric Ltd. Business Overview Table 139. CellCentric Ltd. Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. CellCentric Ltd. Genomics Products Product Portfolio Table 141. CellCentric Ltd. Recent Development Table 142. ValiRx plc Company Information Table 143. ValiRx plc Business Overview Table 144. ValiRx plc Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. ValiRx plc Genomics Products Product Portfolio Table 146. ValiRx plc Recent Development Table 147. EpiGentek Company Information Table 148. EpiGentek Business Overview Table 149. EpiGentek Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. EpiGentek Genomics Products Product Portfolio Table 151. EpiGentek Recent Development Table 152. Syndax Pharmaceuticals Company Information Table 153. Syndax Pharmaceuticals Business Overview Table 154. Syndax Pharmaceuticals Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Syndax Pharmaceuticals Genomics Products Product Portfolio Table 156. Syndax Pharmaceuticals Recent Development Table 157. Spectrum Pharmaceuticals Company Information Table 158. Spectrum Pharmaceuticals Business Overview Table 159. Spectrum Pharmaceuticals Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Spectrum Pharmaceuticals Genomics Products Product Portfolio Table 161. Spectrum Pharmaceuticals Recent Development Table 162. Promega Company Information Table 163. Promega Business Overview Table 164. Promega Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Promega Genomics Products Product Portfolio Table 166. Promega Recent Development Table 167. Novartis Company Information Table 168. Novartis Business Overview Table 169. Novartis Genomics Products Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Novartis Genomics Products Product Portfolio Table 171. Novartis Recent Development Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Genomics Products Distributors List Table 175. Genomics Products Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Genomics Products Product Image Figure 2. Global Genomics Products Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genomics Products Sales Value (2021-2032) & (US$ Million) Figure 4. Global Genomics Products Sales (2021-2032) & (k units) Figure 5. Global Genomics Products Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Genomics Products Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Reagents and Consumables Image Figure 10. Bioinformatics and Software Image Figure 11. Instruments and Systems Image Figure 12. Others Image Figure 13. Global Genomics Products Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Genomics Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Genomics Products Sales Volume Share by Type (2021-2032) Figure 16. Global Genomics Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Genomics Products Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Genomics Products Sales Value Share by Type (2021-2032) Figure 19. Pharmaceutical & Biotechnological Image Figure 20. Companies Academic & Research Institutes Contract Image Figure 21. Research Organizations Image Figure 22. Others Image Figure 23. Global Genomics Products Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Genomics Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Genomics Products Sales Volume Share by Application (2021-2032) Figure 26. Global Genomics Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Genomics Products Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Genomics Products Sales Value Share by Application (2021-2032) Figure 29. Global Genomics Products Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Genomics Products Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Genomics Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Genomics Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Genomics Products Sales Value (2021-2032) & (US$ Million) Figure 34. North America Genomics Products Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Genomics Products Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Genomics Products Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Genomics Products Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Genomics Products Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Genomics Products Sales Value (2021-2032) & (US$ Million) Figure 40. South America Genomics Products Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Genomics Products Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Genomics Products Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Genomics Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Genomics Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Genomics Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Genomics Products Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Genomics Products Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Reagents and Consumables
  • Bioinformatics and Software
  • Instruments and Systems
  • Others
Applications
  • Pharmaceutical & Biotechnological
  • Companies Academic & Research Institutes Contract
  • Research Organizations
  • Others
Companies covered
  • Zymo Research
  • Active Motif
  • Thermo Fisher Scientific
  • Cayman Chemical
  • Diagenode
  • Abcam
  • New England Biolabs
  • Merck & Co.
  • Qiagen
  • Bio-Rad
  • Illumina
  • Agilent
  • Perkinelmer
  • Epizyme Inc.
  • CellCentric Ltd.
  • ValiRx plc
  • EpiGentek
  • Syndax Pharmaceuticals
  • Spectrum Pharmaceuticals
  • Promega
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Genomics Products Sales Value (2021-2032)
  4. 1.2.2 Global Genomics Products Sales Volume (2021-2032)
  5. 1.2.3 Global Genomics Products Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Genomics Products Market Dynamics
  1. 2.1 Genomics Products Industry Trends
  2. 2.2 Genomics Products Industry Drivers
  3. 2.3 Genomics Products Industry Opportunities and Challenges
  4. 2.4 Genomics Products Industry Restraints
3 Genomics Products Market by Company
  1. 3.1 Global Genomics Products Company Revenue Ranking in 2025
  2. 3.2 Global Genomics Products Revenue by Company (2021-2026)
  3. 3.3 Global Genomics Products Sales Volume by Company (2021-2026)
  4. 3.4 Global Genomics Products Average Price by Company (2021-2026)
  5. 3.5 Global Genomics Products Company Ranking (2024-2026)
  6. 3.6 Global Genomics Products Company Manufacturing Base and Headquarters
  7. 3.7 Global Genomics Products Company Product Type and Application
  8. 3.8 Global Genomics Products Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Genomics Products Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Genomics Products Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Genomics Products Market by Type
  1. 4.1 Genomics Products Type Introduction
  2. 4.1.1 Reagents and Consumables
  3. 4.1.2 Bioinformatics and Software
  4. 4.1.3 Instruments and Systems
  5. 4.1.4 Others
  6. 4.2 Global Genomics Products Sales Volume by Type
  7. 4.2.1 Global Genomics Products Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Genomics Products Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Genomics Products Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Genomics Products Sales Value by Type
  11. 4.3.1 Global Genomics Products Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Genomics Products Sales Value by Type (2021-2032)
  13. 4.3.3 Global Genomics Products Sales Value Share by Type (2021-2032)
5 Genomics Products Market by Application
  1. 5.1 Genomics Products Application Introduction
  2. 5.1.1 Pharmaceutical & Biotechnological
  3. 5.1.2 Companies Academic & Research Institutes Contract
  4. 5.1.3 Research Organizations
  5. 5.1.4 Others
  6. 5.2 Global Genomics Products Sales Volume by Application
  7. 5.2.1 Global Genomics Products Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Genomics Products Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Genomics Products Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Genomics Products Sales Value by Application
  11. 5.3.1 Global Genomics Products Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Genomics Products Sales Value by Application (2021-2032)
  13. 5.3.3 Global Genomics Products Sales Value Share by Application (2021-2032)
6 Genomics Products Regional Sales and Value Analysis
  1. 6.1 Global Genomics Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genomics Products Sales by Region (2021-2032)
  3. 6.2.1 Global Genomics Products Sales by Region: 2021-2026
  4. 6.2.2 Global Genomics Products Sales by Region (2027-2032)
  5. 6.3 Global Genomics Products Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Genomics Products Sales Value by Region (2021-2032)
  7. 6.4.1 Global Genomics Products Sales Value by Region: 2021-2026
  8. 6.4.2 Global Genomics Products Sales Value by Region (2027-2032)
  9. 6.5 Global Genomics Products Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Genomics Products Sales Value (2021-2032)
  12. 6.6.2 North America Genomics Products Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Genomics Products Sales Value (2021-2032)
  15. 6.7.2 Europe Genomics Products Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Genomics Products Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Genomics Products Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Genomics Products Sales Value (2021-2032)
  21. 6.9.2 South America Genomics Products Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Genomics Products Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Genomics Products Sales Value Share by Country, 2025 VS 2032
7 Genomics Products Country-level Sales and Value Analysis
  1. 7.1 Global Genomics Products Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Genomics Products Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Genomics Products Sales by Country (2021-2032)
  4. 7.3.1 Global Genomics Products Sales by Country (2021-2026)
  5. 7.3.2 Global Genomics Products Sales by Country (2027-2032)
  6. 7.4 Global Genomics Products Sales Value by Country (2021-2032)
  7. 7.4.1 Global Genomics Products Sales Value by Country (2021-2026)
  8. 7.4.2 Global Genomics Products Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Genomics Products Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Genomics Products Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Genomics Products Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Genomics Products Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Genomics Products Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Genomics Products Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Genomics Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Genomics Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Genomics Products Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Genomics Products Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Genomics Products Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Genomics Products Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Genomics Products Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Genomics Products Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Genomics Products Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Genomics Products Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Genomics Products Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Genomics Products Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Genomics Products Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Genomics Products Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Genomics Products Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Genomics Products Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Genomics Products Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Genomics Products Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Genomics Products Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Genomics Products Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Genomics Products Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Genomics Products Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Genomics Products Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Genomics Products Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Genomics Products Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Genomics Products Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Genomics Products Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Genomics Products Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Genomics Products Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Genomics Products Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Genomics Products Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Genomics Products Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Genomics Products Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Genomics Products Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Genomics Products Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Genomics Products Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Genomics Products Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Genomics Products Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Genomics Products Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Genomics Products Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Genomics Products Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Genomics Products Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Genomics Products Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Genomics Products Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Genomics Products Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Genomics Products Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Genomics Products Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Genomics Products Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Genomics Products Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Genomics Products Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Genomics Products Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Genomics Products Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Genomics Products Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Genomics Products Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Genomics Products Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Genomics Products Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Genomics Products Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Genomics Products Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Genomics Products Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Genomics Products Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Genomics Products Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Genomics Products Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Genomics Products Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Genomics Products Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Genomics Products Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Genomics Products Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Genomics Products Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Genomics Products Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Genomics Products Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Genomics Products Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Genomics Products Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Genomics Products Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Genomics Products Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Genomics Products Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Genomics Products Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Genomics Products Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Genomics Products Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Genomics Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zymo Research
  2. 8.1.1 Zymo Research Company Information
  3. 8.1.2 Zymo Research Business Overview
  4. 8.1.3 Zymo Research Genomics Products Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zymo Research Genomics Products Product Portfolio
  6. 8.1.5 Zymo Research Recent Developments
  7. 8.2 Active Motif
  8. 8.2.1 Active Motif Company Information
  9. 8.2.2 Active Motif Business Overview
  10. 8.2.3 Active Motif Genomics Products Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Active Motif Genomics Products Product Portfolio
  12. 8.2.5 Active Motif Recent Developments
  13. 8.3 Thermo Fisher Scientific
  14. 8.3.1 Thermo Fisher Scientific Company Information
  15. 8.3.2 Thermo Fisher Scientific Business Overview
  16. 8.3.3 Thermo Fisher Scientific Genomics Products Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Scientific Genomics Products Product Portfolio
  18. 8.3.5 Thermo Fisher Scientific Recent Developments
  19. 8.4 Cayman Chemical
  20. 8.4.1 Cayman Chemical Company Information
  21. 8.4.2 Cayman Chemical Business Overview
  22. 8.4.3 Cayman Chemical Genomics Products Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cayman Chemical Genomics Products Product Portfolio
  24. 8.4.5 Cayman Chemical Recent Developments
  25. 8.5 Diagenode
  26. 8.5.1 Diagenode Company Information
  27. 8.5.2 Diagenode Business Overview
  28. 8.5.3 Diagenode Genomics Products Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Diagenode Genomics Products Product Portfolio
  30. 8.5.5 Diagenode Recent Developments
  31. 8.6 Abcam
  32. 8.6.1 Abcam Company Information
  33. 8.6.2 Abcam Business Overview
  34. 8.6.3 Abcam Genomics Products Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Abcam Genomics Products Product Portfolio
  36. 8.6.5 Abcam Recent Developments
  37. 8.7 New England Biolabs
  38. 8.7.1 New England Biolabs Company Information
  39. 8.7.2 New England Biolabs Business Overview
  40. 8.7.3 New England Biolabs Genomics Products Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 New England Biolabs Genomics Products Product Portfolio
  42. 8.7.5 New England Biolabs Recent Developments
  43. 8.8 Merck & Co.
  44. 8.8.1 Merck & Co. Company Information
  45. 8.8.2 Merck & Co. Business Overview
  46. 8.8.3 Merck & Co. Genomics Products Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Merck & Co. Genomics Products Product Portfolio
  48. 8.8.5 Merck & Co. Recent Developments
  49. 8.9 Qiagen
  50. 8.9.1 Qiagen Company Information
  51. 8.9.2 Qiagen Business Overview
  52. 8.9.3 Qiagen Genomics Products Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Qiagen Genomics Products Product Portfolio
  54. 8.9.5 Qiagen Recent Developments
  55. 8.10 Bio-Rad
  56. 8.10.1 Bio-Rad Company Information
  57. 8.10.2 Bio-Rad Business Overview
  58. 8.10.3 Bio-Rad Genomics Products Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bio-Rad Genomics Products Product Portfolio
  60. 8.10.5 Bio-Rad Recent Developments
  61. 8.11 Illumina
  62. 8.11.1 Illumina Company Information
  63. 8.11.2 Illumina Business Overview
  64. 8.11.3 Illumina Genomics Products Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Illumina Genomics Products Product Portfolio
  66. 8.11.5 Illumina Recent Developments
  67. 8.12 Agilent
  68. 8.12.1 Agilent Company Information
  69. 8.12.2 Agilent Business Overview
  70. 8.12.3 Agilent Genomics Products Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Agilent Genomics Products Product Portfolio
  72. 8.12.5 Agilent Recent Developments
  73. 8.13 Perkinelmer
  74. 8.13.1 Perkinelmer Company Information
  75. 8.13.2 Perkinelmer Business Overview
  76. 8.13.3 Perkinelmer Genomics Products Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Perkinelmer Genomics Products Product Portfolio
  78. 8.13.5 Perkinelmer Recent Developments
  79. 8.14 Epizyme Inc.
  80. 8.14.1 Epizyme Inc. Company Information
  81. 8.14.2 Epizyme Inc. Business Overview
  82. 8.14.3 Epizyme Inc. Genomics Products Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Epizyme Inc. Genomics Products Product Portfolio
  84. 8.14.5 Epizyme Inc. Recent Developments
  85. 8.15 CellCentric Ltd.
  86. 8.15.1 CellCentric Ltd. Company Information
  87. 8.15.2 CellCentric Ltd. Business Overview
  88. 8.15.3 CellCentric Ltd. Genomics Products Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CellCentric Ltd. Genomics Products Product Portfolio
  90. 8.15.5 CellCentric Ltd. Recent Developments
  91. 8.16 ValiRx plc
  92. 8.16.1 ValiRx plc Company Information
  93. 8.16.2 ValiRx plc Business Overview
  94. 8.16.3 ValiRx plc Genomics Products Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 ValiRx plc Genomics Products Product Portfolio
  96. 8.16.5 ValiRx plc Recent Developments
  97. 8.17 EpiGentek
  98. 8.17.1 EpiGentek Company Information
  99. 8.17.2 EpiGentek Business Overview
  100. 8.17.3 EpiGentek Genomics Products Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 EpiGentek Genomics Products Product Portfolio
  102. 8.17.5 EpiGentek Recent Developments
  103. 8.18 Syndax Pharmaceuticals
  104. 8.18.1 Syndax Pharmaceuticals Company Information
  105. 8.18.2 Syndax Pharmaceuticals Business Overview
  106. 8.18.3 Syndax Pharmaceuticals Genomics Products Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Syndax Pharmaceuticals Genomics Products Product Portfolio
  108. 8.18.5 Syndax Pharmaceuticals Recent Developments
  109. 8.19 Spectrum Pharmaceuticals
  110. 8.19.1 Spectrum Pharmaceuticals Company Information
  111. 8.19.2 Spectrum Pharmaceuticals Business Overview
  112. 8.19.3 Spectrum Pharmaceuticals Genomics Products Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Spectrum Pharmaceuticals Genomics Products Product Portfolio
  114. 8.19.5 Spectrum Pharmaceuticals Recent Developments
  115. 8.20 Promega
  116. 8.20.1 Promega Company Information
  117. 8.20.2 Promega Business Overview
  118. 8.20.3 Promega Genomics Products Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Promega Genomics Products Product Portfolio
  120. 8.20.5 Promega Recent Developments
  121. 8.21 Novartis
  122. 8.21.1 Novartis Company Information
  123. 8.21.2 Novartis Business Overview
  124. 8.21.3 Novartis Genomics Products Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Novartis Genomics Products Product Portfolio
  126. 8.21.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Genomics Products Value Chain Analysis
  2. 9.1.1 Genomics Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Genomics Products Sales Mode & Process
  6. 9.2 Genomics Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Genomics Products Distributors
  9. 9.2.3 Genomics Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst